One-class classification as a novel method of ligand-based virtual screening: the case of glycogen synthase kinase 3β inhibitors.

MLA

Karpov, Pavel V., et al. “One-Class Classification as a Novel Method of Ligand-Based Virtual Screening: The Case of Glycogen Synthase Kinase 3β Inhibitors.” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 22, Nov. 2011, pp. 6728–31. EBSCOhost, https://doi.org/10.1016/j.bmcl.2011.09.051.

APA

Karpov, P. V., Osolodkin, D. I., Baskin, I. I., Palyulin, V. A., & Zefirov, N. S. (2011). One-class classification as a novel method of ligand-based virtual screening: the case of glycogen synthase kinase 3β inhibitors. Bioorganic & Medicinal Chemistry Letters, 21(22), 6728–6731. https://doi.org/10.1016/j.bmcl.2011.09.051

Chicago

Karpov, Pavel V, Dmitry I Osolodkin, Igor I Baskin, Vladimir A Palyulin, and Nikolay S Zefirov. 2011. “One-Class Classification as a Novel Method of Ligand-Based Virtual Screening: The Case of Glycogen Synthase Kinase 3β Inhibitors.” Bioorganic & Medicinal Chemistry Letters 21 (22): 6728–31. doi:10.1016/j.bmcl.2011.09.051.